Notable Labs Shares Fall 31% After Completing Merger with VBL Therapeutics

By Denny Jacob


Notable Labs shares declined 31% to $3.75 following its completed merger with VBL Therapeutics.

The stock is on pace for a new all-time low and its largest percentage decrease since July 2022.

Trading was paused for volatility twice on Tuesday before resuming at 10:19 a.m. ET.

The clinical stage therapeutic platform company on Monday said it has completed its merger with VBL Therapeutics. Ordinary shares of the combined company began trading on the Nasdaq Capital Market Tuesday following a 1-for-35 reverse stock split.


Write to Denny Jacob at [email protected]


Read the full article here